Shida H, Matsumoto S
Cell. 1983 Jun;33(2):423-34. doi: 10.1016/0092-8674(83)90424-5.
We isolated mutants whose vaccinia hemagglutinin (HA) accumulates on nuclear envelopes and the rough endoplasmic reticulum. Mutant HA must be blocked at a pre-Golgi step because it has high-mannose-type carbohydrates but no fucose. Neither N- nor O-glycosidically linked carbohydrates are involved in the transport defect of the mutant HA, because tunicamycin, an inhibitor of N-type glycosylation, has no effect, and O-type glycosylation takes place in the Golgi organelle. The unglycosylated form of the mutant HA synthesized in the presence of tunicamycin is 3000 daltons larger than the wild type. This higher molecular weight is related to the transport defect. HAs translated in vitro also show this difference, evidence that it reflects mutation in the HA structural gene. Portions of HAs that project into the cytoplasm seem to account for this weight difference. Thus the cytoplasmic tail of glycoprotein has an important function in transport out of the rough endoplasmic reticulum.
我们分离出了痘苗血凝素(HA)在核膜和糙面内质网上积累的突变体。突变型HA必定在高尔基体前的步骤被阻断,因为它具有高甘露糖型碳水化合物但没有岩藻糖。N-糖基化连接的碳水化合物和O-糖基化连接的碳水化合物都不参与突变型HA的转运缺陷,因为N-型糖基化抑制剂衣霉素没有作用,且O-型糖基化发生在高尔基体细胞器中。在衣霉素存在的情况下合成的突变型HA的未糖基化形式比野生型大3000道尔顿。这种更高的分子量与转运缺陷有关。体外翻译的HA也显示出这种差异,这证明它反映了HA结构基因中的突变。HA伸入细胞质的部分似乎是造成这种重量差异的原因。因此,糖蛋白的细胞质尾部在从糙面内质网转运出去的过程中具有重要作用。